Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational Studies.

antibiotics cancer meta-analysis risk factor

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
14 Aug 2019
Historique:
received: 31 07 2019
revised: 10 08 2019
accepted: 11 08 2019
entrez: 17 8 2019
pubmed: 17 8 2019
medline: 17 8 2019
Statut: epublish

Résumé

The association between antibiotic use and risk of cancer development is unclear, and clinical trials are lacking. We performed a systematic review and meta-analysis of observational studies to assess the association between antibiotic use and risk of cancer. PubMed, the Cochrane Library and EMBASE were searched from inception to 24 February 2019 for studies reporting antibiotic use and subsequent risk of cancer. We included observational studies of adult subjects with previous exposure to antibiotics and available information on incident cancer diagnoses. For each of the eligible studies, data were collected by three reviewers. Risk of cancer was pooled to provide an adjusted odds ratio (OR) with a 95% confidence interval (CI). The primary outcome was the risk of developing cancer in ever versus non-antibiotic users. Cancer risk's association with antibiotic intake was evaluated among 7,947,270 participants (

Identifiants

pubmed: 31416208
pii: cancers11081174
doi: 10.3390/cancers11081174
pmc: PMC6721461
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Br J Cancer. 2000 Mar;82(5):1107-10
pubmed: 10737394
JAMA. 2000 Apr 19;283(15):2008-12
pubmed: 10789670
Cancer Res. 2000 Nov 15;60(22):6376-80
pubmed: 11103800
Int J Cancer. 2003 Oct 20;107(1):99-105
pubmed: 12925963
JAMA. 2004 Feb 18;291(7):827-35
pubmed: 14970061
Br J Cancer. 2005 Feb 14;92(3):594-6
pubmed: 15611791
Am J Epidemiol. 2005 Apr 1;161(7):616-9
pubmed: 15781950
Breast Cancer Res Treat. 2005 Jul;92(2):163-7
pubmed: 15986126
Epidemiology. 2005 Sep;16(5):688-90
pubmed: 16135947
Am J Epidemiol. 2005 Nov 15;162(10):965-74
pubmed: 16192343
J Clin Microbiol. 2005 Nov;43(11):5588-92
pubmed: 16272491
Gut. 2006 Jun;55(6):793-6
pubmed: 16551654
Cancer Epidemiol Biomarkers Prev. 2006 Nov;15(11):2102-6
pubmed: 17119034
Pharmacoepidemiol Drug Saf. 2008 Feb;17(2):144-50
pubmed: 17943999
Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1308-15
pubmed: 18544646
Int J Cancer. 2008 Nov 1;123(9):2152-5
pubmed: 18704945
BMC Res Notes. 2009 Apr 17;2:57
pubmed: 19374749
Int J Cancer. 2010 Aug 15;127(4):952-60
pubmed: 20039321
Pharmacoepidemiol Drug Saf. 2010 Nov;19(11):1101-7
pubmed: 20845408
Proc Natl Acad Sci U S A. 2011 Mar 15;108 Suppl 1:4554-61
pubmed: 20847294
Eur J Obstet Gynecol Reprod Biol. 2011 Dec;159(2):388-93
pubmed: 21741150
ISME J. 2012 Feb;6(2):320-9
pubmed: 21850056
Genome Res. 2012 Feb;22(2):292-8
pubmed: 22009990
Int J Cancer. 2012 Oct 1;131(7):E1158-65
pubmed: 22552810
Trends Immunol. 2012 Sep;33(9):459-66
pubmed: 22677185
Curr Opin Microbiol. 2013 Apr;16(2):221-7
pubmed: 23597788
Int J Cancer. 2014 Aug 15;135(4):956-67
pubmed: 24470385
Cancer J. 2014 May-Jun;20(3):190-4
pubmed: 24855006
Nat Rev Urol. 2015 Feb;12(2):81-90
pubmed: 25600098
Pharmacoepidemiol Drug Saf. 2015 May;24(5):534-42
pubmed: 25808540
Dig Dis Sci. 2016 Jan;61(1):255-64
pubmed: 26289256
Eur J Cancer. 2015 Nov;51(17):2655-64
pubmed: 26338196
Science. 2015 Nov 27;350(6264):1079-84
pubmed: 26541610
BMC Infect Dis. 2015 Nov 25;15:545
pubmed: 26607324
JAMA. 2016 Feb 9;315(6):562-70
pubmed: 26864410
Medicine (Baltimore). 2016 Mar;95(13):e3077
pubmed: 27043670
Genome Med. 2016 Apr 13;8(1):39
pubmed: 27074706
Science. 2016 Apr 29;352(6285):544-5
pubmed: 27126037
Trends Mol Med. 2016 Jun;22(6):458-478
pubmed: 27178527
Br J Cancer. 2016 Jun 28;115(1):85-9
pubmed: 27219020
Int J Cancer. 2017 Apr 15;140(8):1828-1835
pubmed: 28120338
JAMA Intern Med. 2017 Aug 1;177(8):1130-1138
pubmed: 28459929
Cancer Lett. 2017 Aug 28;402:9-15
pubmed: 28527946
Nat Rev Microbiol. 2017 Aug;15(8):465-478
pubmed: 28529325
Eur Urol Focus. 2018 Jan;4(1):128-138
pubmed: 28753805
Science. 2018 Jan 5;359(6371):91-97
pubmed: 29097494
Science. 2017 Dec 15;358(6369):1443-1448
pubmed: 29170280
Cancer Lett. 2018 Feb 28;415:40-48
pubmed: 29197615
Cell Host Microbe. 2017 Dec 13;22(6):757-765.e3
pubmed: 29199098
PLoS One. 2018 Apr 12;13(4):e0195690
pubmed: 29649268
Intest Res. 2018 Jul;16(3):338-345
pubmed: 30090032
Microorganisms. 2019 Jan 10;7(1):null
pubmed: 30634578
BMJ. 1997 Sep 13;315(7109):629-34
pubmed: 9310563

Auteurs

Fausto Petrelli (F)

Oncology Unit, Oncology Department, ASST Bergamo Ovest, 24047 Treviglio (BG), Italy. faupe@libero.it.

Michele Ghidini (M)

Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.

Antonio Ghidini (A)

Medical Oncology Unit, Casa di Cura Igea, 20129 Milan, Italy.

Gianluca Perego (G)

Pharmacy Unit, School of Hospital Pharmacy-University of Milan, ASST Bergamo Ovest, 24047 Treviglio (BG), Italy.

Mary Cabiddu (M)

Oncology Unit, Oncology Department, ASST Bergamo Ovest, 24047 Treviglio (BG), Italy.

Shelize Khakoo (S)

Department of Medicine, Royal Marsden Hospital, London and Surrey, Sutton SM2 5PT, UK.

Emanuela Oggionni (E)

Pharmacy Unit, ASST Bergamo Ovest, 24047 Treviglio (BG), Italy.

Chiara Abeni (C)

Oncology Unit, Fondazione Poliambulanza, 25124 Brescia, Italy.

Jens Claus Hahne (JC)

Division of Molecular Pathology, The Institute of Cancer Research, Sutton, London SM2 5NG, UK.

Gianluca Tomasello (G)

Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, 20162 Milan, Italy.

Alberto Zaniboni (A)

Oncology Unit, Fondazione Poliambulanza, 25124 Brescia, Italy.

Classifications MeSH